<i>BRCA1/2</i> Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study
2018 · Journal of Clinical Oncology · 101 citations
https://doi.org/10.1200/jco.2017.77.2285